Neutrophil to Lymphocyte Ratio (NLR) in Peripheral Blood: A Novel and Simple Prognostic Predictor of Non-small Cell Lung Cancer (NSCLC)

Article Sidebar

PDF HTML
Submitted: February 27, 2017
Published: Mar 30, 2017
DOI: 10.29328/journal.jhcr.1001002
Keywords:
Neutrophil to Lymphocyte Ratio, NLR, Prognostic Predictor, Systematic Inflammation, Non-small Cell Lung Cancer, NSCLC

Main Article Content

Xiaoli Zhang
Department of Respiratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P. R. China
Ziyuan Zou
Department of Respiratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P. R. China
Liyu Fan
Department of Respiratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P. R. China
Xinjie Xu
Department of Respiratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P. R. China
Yu Siyuan
Department of Respiratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P. R. China
Peng Luo
Department of Respiratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P. R. China

Article Details

Zhang, X., Zou, Z., Fan, L., Xu, X., Siyuan, Y., & Luo, P. (2017). Neutrophil to Lymphocyte Ratio (NLR) in Peripheral Blood: A Novel and Simple Prognostic Predictor of Non-small Cell Lung Cancer (NSCLC). Journal of Hematology and Clinical Research, 1(1), 011–013. https://doi.org/10.29328/journal.jhcr.1001002
Editorials

Copyright (c) 2017 Zhang X et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Dirican N, Dirican A, Anar C, Atalay S, Ozturk O, et al. A New Inflammatory Prognostic Index, Based on C-reactive protein, the Neutrophil to Lymphocyte Ratio and Serum Albumin is Useful for Predicting Prognosis in Non-Small Cell Lung Cancer Cases. Asian Pac J Cancer Prev. 2016; 17: 5101-5106. Ref.: https://goo.gl/k3vLfQ

Wang J, Kalhor N, Hu J, Wang B, Chu H, et al. Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer. PloS one. 2016; 11. Ref.: https://goo.gl/GjnBc1

Jin F, Han A, Shi F, Kong L, Yu J, et al. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer. OncoTargets ther. 2016; 9: 6529-6537. Ref.: https://goo.gl/tAJlnN

Tomita M, Shimizu T, Ayabe T, Nakamura K, Onitsuka T, et al. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer. Anticancer res. 2012; 32: 3535-3538. Ref.: https://goo.gl/ZM93k9

Gu XB, Tian T, Tian XJ, Zhang XJ. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis. Sci Rep. 2015; 5: 12493. Ref.: https://goo.gl/jOfxEL

Peng B, Wang Y H, Liu Y M, Ma LX. Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis. Int J Clin Exp Med. 2015; 8: 3098-3106. Ref.: https://goo.gl/XJ7Prw

Eryilmaz M K, Mutlu H, Salim D K, Musri FY, Tural D, et al. The neutrophil to lymphocyte ratio has a high negative predictive value for pathologic complete response in locally advanced breast cancer patients receiving neoadjuvant chemotherapy. Asian Pac J Cancer Prev. 2014; 15: 7737-7740. Ref.: https://goo.gl/vgeXCu